根据造影剂诱发急性肾损伤的预测风险为经皮冠状动脉介入治疗患者分配造影剂节省策略的临床和经济效果

IF 2.9 4区医学 Q2 HEALTH CARE SCIENCES & SERVICES

Journal of Medical Economics Pub Date : 2024-04-18 DOI:10.1080/13696998.2024.2334180

Robert I. Griffiths, Aparna Bhave, Alysha M. McGovern, Liesl M. Hargens, Craig A. Solid, Amit P. Amin

引用次数: 0

摘要

针对造影剂诱发急性肾损伤（CI-AKI）风险增高的经皮冠状动脉介入治疗（PCI）患者，已经开发出了造影剂保护策略，并制定了许多CI-AKI风险预防措施。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Clinical and economic outcomes of assigning percutaneous coronary intervention patients to contrast-sparing strategies based on the predicted risk of contrast-induced acute kidney injury

Contrast-sparing strategies have been developed for percutaneous coronary intervention (PCI) patients at increased risk of contrast-induced acute kidney injury (CI-AKI), and numerous CI-AKI risk pr...

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Medical Economics HEALTH CARE SCIENCES & SERVICES-MEDICINE, GENERAL & INTERNAL

CiteScore

4.50

自引率

4.20%

发文量

122

期刊介绍： Journal of Medical Economics'' mission is to provide ethical, unbiased and rapid publication of quality content that is validated by rigorous peer review. The aim of Journal of Medical Economics is to serve the information needs of the pharmacoeconomics and healthcare research community, to help translate research advances into patient care and be a leader in transparency/disclosure by facilitating a collaborative and honest approach to publication. Journal of Medical Economics publishes high-quality economic assessments of novel therapeutic and device interventions for an international audience